Potential of electrospun fibrous membranes involving tri-n-octylphosphine oxide for selective clearance of uremic toxin p-cresol over urea and creatinine

In this study, various electrospun and electrosprayed fibrous membranes from polyethersulfone (PES) and polyvinylpyrrolidone (PVP) were fabricated, to which a common solvating extractant tri-n-octylphosphine oxide (TOPO) was incorporated. Such TOPO-involved PES membranes were attempted to selectively clear p-cresol, one of trace amounts of small uremic toxins, from simulated serum via hydrogen bonding. Morphological and physicochemical properties of the as-synthesized fibrous membranes were first studied. Batch tests displayed that the equilibrium of p-cresol adsorption on all fibrous membranes were attained within 2 h. Analysis of adsorption isotherms of p-cresol by the Langmuir equation revealed that the adsorption was improved in the presence of TOPO; moreover, the distribution state of TOPO powders along the fibers played an important role in membrane performance. Among the six as-prepared TOPO-incorporated membranes, the highest adsorption capacity of p-cresol in simulated serum at 37^oC and pH 7.4 reached to be 21.7 mmol per gram of TOPO. The operational stability of as-prepared fibrous membranes was evaluated by checking their adsorption ability, membrane weight, water contact angle, structural changes by SEM imaging, and PVP dissolution using UV–Vis spectroscopy, both before and after exposure to PBS solution. Crossflow permeation-adsorption of a multicomponent mixture (0.46 mmol/L of p-cresol, 1.33 mmol/L of creatinine, and 38.3 mmol/L of urea) for 4 h indicated that the prepared membranes yielded a high selectivity toward p-cresol against creatinine and urea of 21.2–43.0 and 10.8–18.5, respectively. Hemolysis tests and viability measurements of both human umbilical vein endothelial cells and THP 1 monocytic leukemia cells demonstrated that the proposed configurations of the TOPO-incorporated fibrous membranes were hemo- and bio-compatible. Our results on the composition and systematic design of these fibrous membranes suggested that they can serve as an advanced hemoperfusion unit, maintaining high p-cresol removal and bio-compatibility. These well-designed membrane-based devices could be connected in series with the conventional hemodialysis devices to further improve the overall removal of small uremic toxins.